Linezolid som behandling af infektiøs endokarditis

Trine Kiilerich Lauridsen, Magnus Arpi, Niels Eske Bruun

1 Citationer (Scopus)


In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.
Bidragets oversatte titel[Linezolid therapy for infectious endocarditis]
TidsskriftUgeskrift for Laeger
Udgave nummer16
Sider (fra-til)1215-6
Antal sider2
StatusUdgivet - 19 apr. 2010


Dyk ned i forskningsemnerne om 'Linezolid som behandling af infektiøs endokarditis'. Sammen danner de et unikt fingeraftryk.